To access this element change to forms mode OFF
Grant Award View - GA29793
Treatment of cardiovascular disease with very low dose Rivaroxaban in...
GA ID:
GA29793
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2023
Value (AUD):
$5,522,417.59
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Treatment of cardiovascular disease with very low dose Rivaroxaban in Advanced Chronic Kidney disease (The TRACK Trial)
Purpose:
Patients with advanced stages of chronic kidney disease, including those receiving life-sustaining dialysis, suffer from significant burden of heart and vascular disease. Because of increased dangers of both clotting and bleeding, treatment of heart disease with blood-thinning medications is challenging in these patients. The TRACK trial will evaluate whether a small dose of rivaroxaban, a new blood-thinning medication, would reduce death or major events due to heart and vascular disease.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162375
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA